Related references
Note: Only part of the references are listed.Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions
Andrija Matetic et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association
Tochi M. Okwuosa et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)
Cardio-oncology for the general cardiologist
Li-Ling Tan et al.
HEART (2021)
Fatal heart disease among cancer patients
Kelsey C. Stoltzfus et al.
NATURE COMMUNICATIONS (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL (2019)
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
Helen Strongman et al.
LANCET (2019)
A population-based study of cardiovascular diseasemortality risk in US cancer patients
Kathleen M. Sturgeon et al.
EUROPEAN HEART JOURNAL (2019)
Association of Cardiovascular Disease With Premature Mortality in the United States
Yingxi Chen et al.
JAMA CARDIOLOGY (2019)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2018)
Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies
Roberta Florido et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications
Juana Virginia Tapia-Vieyra et al.
ARCHIVES OF MEDICAL RESEARCH (2017)
How I monitor long-term and late effects after blood or marrow transplantation
Smita Bhatia et al.
BLOOD (2017)
Maximizing anthracycline tolerability in hematologic malignancies: Treat to each heart's content
Guilherme H. Oliveira et al.
BLOOD REVIEWS (2016)
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
Sean A. Virani et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
Shared Risk Factors in Cardiovascular Disease and Cancer
Ryan J. Koene et al.
CIRCULATION (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
Peter Valent et al.
BLOOD (2015)
Arterial hypertension and cancer
Alberto Milan et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Patient age is related to decision-making, treatment selection, and perceived quality of life in breast cancer survivors
Terence T. Sio et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Mechanisms of Disease Proteotoxicity and Cardiac Dysfunction - Alzheimer's Disease of the Heart?
Monte S. Willis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Maria Volkova et al.
CURRENT CARDIOLOGY REVIEWS (2011)
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
P. J. Barrett-Lee et al.
ANNALS OF ONCOLOGY (2009)
Anthracycline-induced cardiotoxicity in adult hematologic malignancies
S. A. Johnson
SEMINARS IN ONCOLOGY (2006)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
